New Delhi: In a major consolidation move in the domestic
pharma sector, drug firm Torrent Pharmaceuticals today said it will
acquire the branded business of Unichem Laboratories in India and Nepal
for Rs 3,600 crore.
Unichem’s business under consideration comprises a portfolio of over 120 products, manufacturing plant at Sikkim catering to these two markets and all the employees engaged in it, Torrent Pharmaceuticals said in a filing to the BSE.
